Spectral Medical (EDT) Competitors C$0.85 +0.01 (+1.19%) As of 07/11/2025 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock EDT vs. AKU, GEN, LMD, LXG, SQD, DXD, MBI, BUX, CRL, and NBLYShould you be buying Spectral Medical stock or one of its competitors? The main competitors of Spectral Medical include Akumin (AKU), GeneNews (GEN), LED Medical Diagnostics (LMD), LexaGene (LXG), SQI Diagnostics (SQD), 3D Signatures (DXD), Med Biogene (MBI), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), and Neighbourly Pharmacy (NBLY). These companies are all part of the "medical" sector. Spectral Medical vs. Its Competitors Akumin GeneNews LED Medical Diagnostics LexaGene SQI Diagnostics 3D Signatures Med Biogene Biomark Diagnostics Charles River Laboratories International Neighbourly Pharmacy Spectral Medical (TSE:EDT) and Akumin (TSE:AKU) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk. Is EDT or AKU more profitable? Spectral Medical has a net margin of 0.00% compared to Akumin's net margin of -34.67%. Akumin's return on equity of -483.86% beat Spectral Medical's return on equity.Company Net Margins Return on Equity Return on Assets Spectral MedicalN/A -973.97% -93.22% Akumin -34.67%-483.86%0.47% Do institutionals & insiders believe in EDT or AKU? 13.0% of Spectral Medical shares are owned by institutional investors. Comparatively, 30.3% of Akumin shares are owned by institutional investors. 18.2% of Spectral Medical shares are owned by company insiders. Comparatively, 33.0% of Akumin shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, EDT or AKU? Spectral Medical has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, Akumin has a beta of 0.15, suggesting that its share price is 85% less volatile than the S&P 500. Does the media prefer EDT or AKU? In the previous week, Akumin's average media sentiment score of 0.00 beat Spectral Medical's score of -0.10 indicating that Akumin is being referred to more favorably in the news media. Company Overall Sentiment Spectral Medical Neutral Akumin Neutral Which has preferable earnings & valuation, EDT or AKU? Spectral Medical has higher earnings, but lower revenue than Akumin. Spectral Medical is trading at a lower price-to-earnings ratio than Akumin, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpectral MedicalC$1.90M125.82-C$18.68M-C$0.07-12.14AkuminC$737.69M0.00-C$255.80M-C$3.80N/A SummaryAkumin beats Spectral Medical on 7 of the 11 factors compared between the two stocks. Get Spectral Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for EDT and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EDT vs. The Competition Export to ExcelMetricSpectral MedicalDiagnostics & Research IndustryMedical SectorTSE ExchangeMarket CapC$239.06MC$779.39MC$5.61BC$6.20BDividend Yield1.45%5.44%5.24%6.72%P/E Ratio-12.142.0527.9650.47Price / Sales125.82496.00430.891,211.67Price / Cash82.5011.4237.4683.29Price / Book-10.632.768.044.70Net Income-C$18.68MC$334.07BC$3.18BC$301.20M7 Day Performance3.66%-0.35%3.67%1.03%1 Month Performance-3.41%-3.41%4.09%4.02%1 Year Performance63.46%-9.61%29.58%25.97% Spectral Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EDTSpectral MedicalN/AC$0.85+1.2%N/A+63.5%C$239.06MC$1.90M-12.1429AKUAkuminN/AN/AN/AN/AC$37.20MC$737.69M-0.141,527GENGeneNewsN/AN/AN/AN/AC$25.49MC$234.59K-2.212,700LMDLED Medical DiagnosticsN/AC$0.40+∞N/A+0.0%C$15.51MC$14.96M-10.2646Gap UpLXGLexaGeneN/AC$0.11-19.2%N/A+0.0%C$14.77MC$110.93K-1.3141High Trading VolumeSQDSQI DiagnosticsN/AC$0.02flatN/A+0.0%C$6.11MC$3.04M-0.30147,000Gap UpDXD3D SignaturesN/AC$0.04+∞N/A+0.0%C$2.66MN/A-0.91N/AGap UpMBIMed BiogeneN/AC$0.05-18.2%N/A+0.0%C$597KN/A-7.5080Gap DownBUXBiomark DiagnosticsN/AN/AN/AN/A$0.00N/A0.00N/AGap DownHigh Trading VolumeCRLCharles River Laboratories InternationalN/AN/AN/AN/A$0.00N/A0.0021,400Gap DownNBLYNeighbourly PharmacyN/AN/AN/AN/AC$835.51MC$874.61M-25.483,648High Trading Volume Related Companies and Tools Related Companies Akumin Competitors GeneNews Competitors LED Medical Diagnostics Competitors LexaGene Competitors SQI Diagnostics Competitors 3D Signatures Competitors Med Biogene Competitors Biomark Diagnostics Competitors Charles River Laboratories International Competitors Neighbourly Pharmacy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:EDT) was last updated on 7/12/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectral Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectral Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.